What is the recommended dosage of cefuroxime (Cefuroxime) injection for treating bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefuroxime Injection Dosage

For most bacterial infections in adults, administer cefuroxime 750 mg to 1.5 grams intravenously every 8 hours for 5-10 days, with the specific dose determined by infection severity and site. 1

Adult Dosing by Infection Type

Standard Infections

  • Uncomplicated infections (urinary tract, skin/soft tissue, uncomplicated pneumonia): 750 mg IV every 8 hours 1
  • Severe or complicated infections: 1.5 grams IV every 8 hours 1
  • Bone and joint infections: 1.5 grams IV every 8 hours 1

Life-Threatening Infections

  • Critical infections or less susceptible organisms: 1.5 grams IV every 6 hours 1
  • Bacterial meningitis: Up to 3 grams IV every 8 hours (maximum dose) 1

Specific Indications

  • Uncomplicated gonorrhea: 1.5 grams IM as single dose at 2 different sites with 1 gram oral probenecid 1

Surgical Prophylaxis Dosing

General Surgery

  • Clean-contaminated procedures: 1.5 grams IV 30-60 minutes before incision, then 750 mg IV/IM every 8 hours if procedure is prolonged 1

Cardiac Surgery

  • Open heart surgery: 1.5 grams IV at anesthesia induction, then every 12 hours for total of 6 grams 1
  • Alternative cardiac prophylaxis: 1.5 grams IV + 0.75 grams in priming solution, with 0.75 gram reinjection every 2 hours intraoperatively 2

Vascular Surgery

  • Arterial procedures (carotid with patch, endoprosthesis): 1.5 grams IV slow, single dose; if duration exceeds 2 hours, reinject 0.75 grams 2

Ophthalmologic Surgery

  • Cataract surgery: 1 mg intracameral injection in 0.1 mL at end of procedure 2

Neurosurgery

  • Spine surgery with prosthetic material: 1.5 grams IV as single dose; if duration exceeds 2 hours, reinject 0.75 grams 3

Pediatric Dosing (>3 Months)

  • Standard infections: 50-100 mg/kg/day IV divided every 6-8 hours 1
  • Severe infections: 100 mg/kg/day IV (not exceeding maximum adult dose) 1
  • Bone and joint infections: 150 mg/kg/day IV divided every 8 hours (not exceeding maximum adult dose) 1

Renal Impairment Adjustments

Dosing must be reduced when creatinine clearance is impaired: 1

  • CrCl >20 mL/min: 750 mg to 1.5 grams every 8 hours (standard dosing)
  • CrCl 10-20 mL/min: 750 mg every 12 hours
  • CrCl <10 mL/min: 750 mg every 24 hours
  • Hemodialysis patients: Give additional dose at end of dialysis 1

Pharmacokinetic Considerations

Peak serum concentrations after 750 mg IM reach 16-25 mcg/mL at 1 hour, declining to <4 mcg/mL by 8 hours in patients with normal renal function. 4 IV bolus of 750 mg produces slightly higher peaks around 40 mcg/mL. 4 The serum half-life is approximately 1.1 hours with nearly complete urinary excretion in 24 hours. 5

For optimal bactericidal activity, maintain serum concentrations above the MIC for at least 40-50% of the dosing interval. 2 Recent pharmacodynamic modeling demonstrates that 750 mg every 12 hours achieves >99% probability of target attainment for Streptococcus pneumoniae, while Staphylococcus aureus requires 1500 mg every 8 hours for >97% probability. 6

Duration of Therapy

  • Most infections: 5-10 days minimum 1
  • Continue 48-72 hours after symptom resolution or bacterial eradication 1
  • Streptococcal infections: Minimum 10 days to prevent rheumatic fever or glomerulonephritis 1
  • Chronic urinary tract infections: May require several weeks with frequent monitoring 1

Critical Caveats

Never use doses smaller than those indicated above. 1 For staphylococcal infections with purulent collections, surgical drainage is mandatory as adjunct to antibiotic therapy. 1 In surgical prophylaxis, the injection must end at latest at the beginning of intervention, ideally 30 minutes before incision. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cefuroxime for Spinal Fixation Suppressive Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cefuroxime in soft tissue infections and septicaemia.

Scandinavian journal of infectious diseases, 1980

Research

The pharmacokinetics of cefuroxime after intravenous injection.

European journal of clinical pharmacology, 1977

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.